SINT Sintx Technologies, Inc.

Nasdaq sintx.com


$ 3.06 $ -0.37 (-10.79 %)    

Thursday, 13-Nov-2025 16:21:25 EST
QQQ $ 608.12 $ -12.68 (-2.04 %)
DIA $ 475.24 $ -8.02 (-1.66 %)
SPY $ 672.24 $ -11.34 (-1.66 %)
TLT $ 89.44 $ -0.74 (-0.82 %)
GLD $ 383.55 $ -3.12 (-0.81 %)
$ 3.06
$ 3.36
$ 3.07 x 1
$ 3.61 x 43
$ 3.06 - $ 3.46
$ 1.71 - $ 8.60
58,844
na
13.21M
$ 1.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-19-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-27-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-29-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-25-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-22-2021 12-31-2020 10-K
21 11-16-2020 09-30-2020 10-Q
22 08-12-2020 06-30-2020 10-Q
23 05-13-2020 03-31-2020 10-Q
24 03-26-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-16-2019 03-31-2019 10-Q
28 03-11-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-29-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 10-31-2017 03-31-2017 10-Q
35 10-31-2017 06-30-2017 10-Q
36 09-20-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-12-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-23-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sintx-technologies-q3-eps-119-misses-051-estimate-sales-208000k-miss-300000k-estimate

SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of ...

 sintx-technologies-receives-fda-510k-clearance-for-its-sinaptic-foot--ankle-osteotomy-wedge-system

SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Com...

 sintx-technologies-launches-osseosculpt

Clinical evaluation of the product by design surgeons completed, driving early commercial momentum

 sintx-technologies-announces-fda-510k-clearance-for-sinaptic-foot--ankle-osteotomy-wedge-system-sintx-plans-us-commercial-launch-in-q1-2026

FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct....

 sintx-technologies-secures-patent-for-antipathogenic-fabric-methods-strengthening-infection-resistant-ip

SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...

 sintx-technologies-expands-patent-protections-for-antipathogenic-fabrics-strengthening-biomedical-ip-portfolio

SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...

 sintx-technologies-enters-atm-agreement-with-hc-wainwright-prospectus-supplement-filed-for-64m-shares-of-common-stock

-SEC Filing

 ascendiant-capital-maintains-buy-on-sintx-technologies-lowers-price-target-to-25

Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from...

 sintx-raises-38m-through-warrant-exercise-to-strengthen-working-capital

SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...

 sintx-technologies-advances-intellectual-property-portfolio-with-uspto-patent-allowance-for-silicon-nitride-antipathogen-innovation-in-medical-devices-and-ppe

Significant Development in the Estimated $30 Billion Global Infection-Prevention Market

 sintx-technologies-appoints-kevin-trask-as-cfo

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001269026/000149315225012731/form8-k.htm

 sintx-technologies-has-received-a-notice-of-allowance-for-a-us-patent-titled-antipathogenic-fibrous-materials-used-on-an-antiviral-face-mask-for-inactivating-andor-preventing-the-transmissin-of-a-virus

https://patentcenter.uspto.gov/applications/17839063/ifw/docs

 why-sintx-technologies-stock-is-skyrocketing-wednesday

Shares of SINTX Technologies are trading sharply higher Wednesday morning. The stock is gaining following the announcement of a...

 sintx-provides-business-update-highlighting-sinaptic-acquisition-and-commercialization-strategy

SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...

 sintx-technologies-q2-eps-091-misses-079-estimate-sales-151000k-miss-400000k-estimate

SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION